RxDoctor Payments Data

Ryan Clark, DO

Interventional Pain Medicine · Green Bay, WINPI 1720499759

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,148 of the $9,545 with a category attached, or 74.9%. It is spread thinly across 22 manufacturers, the largest accounting for just 21.0%. Reporting peaked in 2022 at $2,865 and has fallen 57.6% since, to $1,214 in 2025.

$9,545in general payments, 2019–2025

Across 164 payments — averaging $58.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Medtronic$2K
  • Relievant Medsystems, Inc.$1K
  • Boston Scientific$1K
  • Nevro Corp.$901
  • SPR Therapeutics, Inc$823
  • plus $1K from 16 others

What the payments were for

  • Travel & lodging$2,39625%
  • Food & beverage$7,14875%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,545 in reported general payments places this provider in the 75th percentile of 41 interventional pain medicine providers in Wisconsin.

See all interventional pain medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$304,759
Medicare patients
456
Services billed
15,477

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin469$4,948
Duloxetine Hcl427$4,856
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen174$1,453
Lidocaine23$1,038
Pregabalin54$913
Tizanidine Hcl99$736
Cyclobenzaprine Hcl40$548
Diclofenac Sodium12$337
Methylprednisolone38$261
Amitriptyline Hcl21$255
Nortriptyline Hcl30$240
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen23$233
Baclofen21$199
Tramadol Hcl25$89
Meloxicam16$60

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Green Bay

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →